Literature DB >> 22454947

Effect of the imidazoline-derivative ST-91 on heart rate and blood pressure in healthy man.

K I Saunamäki1.   

Abstract

1 ST-91, 2-(2,6-diethylphenylamino)-2-imidazoline hydrochloride produces in animal experiments bradycardia, and in larger doses, also hypertension, due to α-sympathomimetic activity and probable central sympathetic inhibition. 2 The effects of ST-91, after oral administration, were studied in 10 healthy volunteers. A dose-dependent, significant decrease of the heart rate was observed. On average the resting heart rate was reduced by 11-19 beats/min (15-29%). During exercise the decrease of the heart rate was less pronounced. After the largest dose there was a fall of the systolic blood pressure during exercise averaging at 14-15 mmHg (11-12%). Otherwise the blood pressure remained unchanged. 3 Eight out of the 10 test-subjects complained of hair-raising and goose-flesh after all doses, due to the α-sympathomimetic effect of the drug. No toxic effects were observed.

Entities:  

Year:  1974        PMID: 22454947      PMCID: PMC1402551          DOI: 10.1111/j.1365-2125.1974.tb00236.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  Circulatory effects at rest and exercise of clonidine, an imidazoline derivative with hypotensive properties.

Authors:  A L Muir; J L Burton; D M Lawrie
Journal:  Lancet       Date:  1969-07-26       Impact factor: 79.321

2.  Effect of a new adrenergic beta-blocking agent, H 56-28, on nervous heart complaints.

Authors:  I Nordenfelt; S Persson; A Redfors
Journal:  Acta Med Scand       Date:  1968-12

3.  Observations on the hypotensive action of "Catapres" (ST 155) in man.

Authors:  A J Barnett; S Cantor
Journal:  Med J Aust       Date:  1968-01-20       Impact factor: 7.738

4.  Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). II. Central sympathetic structures.

Authors:  H Schmitt; J R Boissier; J F Giudicelli; J Fichelle
Journal:  Eur J Pharmacol       Date:  1968-03       Impact factor: 4.432

5.  [Blood circulation studies with 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride].

Authors:  W Kobinger; A Walland
Journal:  Arzneimittelforschung       Date:  1967-03

6.  Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-HCl.

Authors:  W Kobinger; A Walland
Journal:  Eur J Pharmacol       Date:  1967-12       Impact factor: 4.432

7.  Beta-blockade and emotional tachycardia; radiotelemetric investigations in ski jumpers.

Authors:  P R Imhof; K Blatter; L M Fuccella; M Turri
Journal:  J Appl Physiol       Date:  1969-09       Impact factor: 3.531

8.  [Pharmacological effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, a new, antihypertensive substance].

Authors:  W Hoefke; W Kobinger
Journal:  Arzneimittelforschung       Date:  1966-08

9.  Potency and time effect relationship in man of propranolol and H 56-28. I. Comparative studies after intravenous administration. II. Studies on the ratio of equipotent oral and intravenous doses.

Authors:  G Johnsson; A Norrby; L Sölvell
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1967

10.  Sleep produced by clonidine (2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride).

Authors:  R B Holman; E E Shillito; M Vogt
Journal:  Br J Pharmacol       Date:  1971-12       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.